- Filed
- Apr 26, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 24, 2024 | 324.99M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2024 | $14.6M |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $151.3M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $1.61B |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $1.62B |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $187.9M |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $139.4M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $1.07B |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $1.07B |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $2.03B |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $2.1B |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $5B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $5.03B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $3.54B |
| Current Assets | Q1 2024 · Dec 31, 2023 | $3.8B |
| Total Assets | Q1 2024 · Mar 31, 2024 | $9.48B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $9.52B |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 329.1M sh |
| Dividends Paid | Q1 2024 · Mar 31, 2023 | $70.6M |
| Capex | Q1 2024 · Mar 31, 2023 | $42.1M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $191.5M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $4.44B |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $4.48B |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.26 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.26 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $68M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $284.8M |
| Net Income | Q1 2024 · Mar 31, 2023 | $85.4M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $115.7M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $771.2M |
| Revenue | Q1 2024 · Mar 31, 2023 | $1.37B |